Resources from the same session
The promise of immune checkpoint inhibitors in endometrial cancer
Presenter: Ana Oaknin
Session: ESMO Colloquium supported by GSK: Breakthroughs in molecular profiling and systemic therapies of endometrial and ovarian cancer
Resources:
Slides
Webcast
Treatment benefit from PARP inhibitors and resistance mechanisms in patients with advanced epithelial ovarian cancer: State of the art and new concepts
Presenter: Mansoor Raza Mirza
Session: ESMO Colloquium supported by GSK: Breakthroughs in molecular profiling and systemic therapies of endometrial and ovarian cancer
Resources:
Slides
Webcast
Emerging combinations of immune checkpoint inhibitors with targeted agents in ovarian and endometrial carcinomas
Presenter: Antonio Jose Gonzalez Martin
Session: ESMO Colloquium supported by GSK: Breakthroughs in molecular profiling and systemic therapies of endometrial and ovarian cancer
Resources:
Slides
Webcast
Key messages and wrap up
Presenter: Jonathan Ledermann
Session: ESMO Colloquium supported by GSK: Breakthroughs in molecular profiling and systemic therapies of endometrial and ovarian cancer
Resources:
Slides
Webcast
Live Q&A
Presenter: Mansoor Raza Mirza
Session: ESMO Colloquium supported by GSK: Breakthroughs in molecular profiling and systemic therapies of endometrial and ovarian cancer
Resources:
Webcast